Bavarian Nordic A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Bavarian Nordic maintains FY 2014 revenue guidance-Ritzau
Bavarian Nordic A/S:Maintains FY 2014 financial guidance-Ritzau.Still expects revenue of about 1,200 million Danish crowns for FY 2014.FY 2014 revenue 1,209 million crowns - Thomson Reuters I/B/E/S.
Latest Developments forBavarian Nordic A/S
- Bavarian Nordic A/S gives FY 2015 guidance
- Bavarian Nordic maintains FY 2014 revenue and EBIT guidance
- Bavarian Nordic A/S enters licensing and supply agreement with Janssen on MVA-BN Ebola Vaccine
- Bavarian Nordic in advanced negotiations on licensing and manufacturing of ebola vaccine candidates; maintains FY 2014 guidance
- Share this
- Digg this